Association of Ipomoea carnea and BCG reduces birth defects caused by cyclophosphamide in rats

Life Sciences

Volumn 80, Issue 5, 2007, Pages 430-435

  Latorre, Andréia Oliveira ^a   Hueza, Isis Machado ^a   Górniak, Silvana Lima ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BCG; Birth defects; Cyclophosphamide; Ipomoea carnea

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; IPOMOEA CARNEA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; DRUG EFFICACY; EMBRYOTOXICITY; FEMALE; FETUS WEIGHT; IMMUNOSTIMULATION; IPOMOEA; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PLACENTA; RAT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CYCLOPHOSPHAMIDE; FEMALE; FETAL WEIGHT; GESTATIONAL AGE; IMMUNOSUPPRESSIVE AGENTS; IPOMOEA; MALE; ORGAN SIZE; PLACENTA; PLANT EXTRACTS; PREGNANCY; RATS; RATS, WISTAR; TERATOGENS;

IPOMOEA CARNEA; MYCOBACTERIUM BOVIS BCG;

EID: 33845778419     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.09.033     Document Type: Article

References (30)

1. Bertini R., Coccia P., Pagani P., Marinello C., Salmona M., and D'Incalci M. Interferon inducers increase O6-alkylguanine-DNA alkyltransferase in the rat liver. Carcinogenesis 11 1 (1990) 181-183
2. Bowlin T.L., McKown B.J., Kang M.S., and Sunkara P.S. Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing. Cancer Research 49 15 (1989) 4109-4113
3. Carlson T.J., and Billings R.E. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Molecular Pharmacology 49 5 (1996) 796-801
4. Chen J.Q., Strom A., Gustafsson J.A., and Morgan E.T. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Molecular Pharmacology 47 5 (1995) 940-947
5. Chernoff N., Rogers J.M., Alles A.J., Zucker R.M., Elstein K.H., Massaro E.J., and Sulik K.K. Cell cycle alterations and cell death in cyclophosphamide teratogenesis. Teratogenesis, Carcinogenesis, and Mutagenesis 9 4 (1989) 199-209
6. Crawford J.H., Yang S., Zhou M., Simms H.H., and Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Critical Care Medicine 32 2 (2004) 502-508
7. Das P.C., Roberts J.D., White S.L., and Olden K. Activation of resident tissue-specific macrophages by swainsonine. Oncology Research 7 9 (1995) 425-433
8. 6-alkylguanine-DNA alkyltransferase. Biochemistry 44 46 (2005) 15396-15405
9. Gomes-Carneiro M.R., De-Oliveira A.C.A.X., De-Carvalho R.R., Araujo I.B., Souza C.A.M., Kuriyama S.N., and Paumgartten F.J. Inhibition of cyclophosphamide-induced teratogenesis by β-ionone. Toxicology Letters 138 3 (2003) 205-213
10. Gorivodsky M., Torchinsky A., Zemliak I., Savion S., Fein A., and Toder V. TGF beta 2 mRNA expression and pregnancy failure in mice. American Journal of Reproductive Immunology 42 2 (1999) 124-133
11. k) expression, and interleukin-1 production by swainsonine. Cancer Communications 1 6 (1989) 373-379
12. Holladay S.D., Sharova L.V., Smith B.J., Gogal Jr. R.M., Ward D.L., and Blaylock B.L. Nonspecific stimulation of the maternal immune system. I. Effects on teratogen-induced fetal malformations. Teratology 62 6 (2000) 413-419
13. Holladay S.D., Sharova L.V., Punareewattana K., Hrubec T.C., Gogal Jr. R.M., Prater M.R., and Sharov A.A. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. International Immunopharmacology 2 2-3 (2002) 325-332
14. Holsapple M.P., Burns-Naas L.A., Hastings K.L., Ladics G.S., Lavin A.L., Markis S.L., Yang Y., and Luster M.I. A proposed testing framework for Developmental Immunotoxicology (DIT). Toxicological Sciences 83 1 (2005) 18-24
15. Hueza I.M., Fonseca E.S., Paulino C.A., Haraguchi M., and Górniak S.L. Evaluation of immunomodulatory activity of Ipomoea carnea on peritoneal cells of rats. Journal of Ethnopharmacology 87 2-3 (2003) 181-186
16. Ivnitsky I., Torchinsky A., Gorivodsky M., Zemliak I., Orenstein H., Savion S., Shepshelovich J., Carp H., Fein A., and Toder V. TNF-alpha expression in embryos exposed to a teratogen. American Journal of Reproductive Immunology 40 6 (1998) 431-440
17. Ke S., Rabson A.B., Germino J.F., Gallo M.A., and Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-α and lipopolysaccharide. The Journal of Biological Chemistry 276 43 (2001) 39638-39644
18. Khatsenko O. Interactions between nitric oxide and cytochrome P-450 in the liver. Biochemistry 63 7 (1998) 833-839
19. Ladics G.S., Chapin R.E., Hastings K.L., Holsapple M.P., Makris S.L., Sheets L.P., Woolhiser M.R., and Burns-Naas L.A. Developmental toxicology evaluations-issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicological Sciences 88 1 (2005) 24-29
20. Matalon S.T., Ornoy A., and Lishner M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Reproductive Toxicology 18 2 (2004) 219-230
21. Mirkes P.E., Greenaway J.C., Rogers J.G., and Brundrett R.B. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro. Toxicology and Applied Pharmacology 72 2 (1984) 281-291
22. Nomura T., Hata S., and Kusafuka T. Suppression of developmental anomalies by maternal macrophages in mice. The Journal of Experimental Medicine 172 5 (1990) 1325-1330
23. Organization for Economic Cooperation and Development. Guideline for testing of Chemicals: Teratogenicity, Paris (1981)
24. Pacifici G.M., and Nottoli R. Placental transfer of drugs administered to the mother. Clinical Pharmacokinetics 28 3 (1995) 235-269
25. Parkinson A. Biotransformation of xenobiotics. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology. The Basic Science of Poisons (2001), McGraw-Hill Inc., New York 133-224
26. Prater M.R., Zimmerman K.L., Ward D.L., and Holladay S.D. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement. Birth Defects Research (Part A): Clinical and Molecular Teratology 70 11 (2004) 862-869
27. Roberts J.D., Klein J.-L.D., Palmantier R., Dhume S.T., George M.D., and Olden K. The role of protein glycosylation inhibitors in the prevention of metastasis and therapy of cancer. Cancer Detection and Prevention 22 5 (1998) 455-462
28. Savion S., Brengauz-Breitmann M., Torchinsky A., and Toder V. A possible role for granulocyte macrophage-colony stimulating factor in modulating teratogen-induced effects. Teratogenesis, Carcinogenesis, and Mutagenesis 19 3 (1999) 171-182
29. Sharova L., Sura P., Smith B.J., Gogal Jr. R.M., Sharov A.A., Ward D.L., and Holladay S.D. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology 62 6 (2000) 420-428
30. Sharova L., Sharov A.A., Sura P., Gogal Jr. R.M., Smith B.J., and Holladay S.D. Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: are these events related to reduced teratogenesis?. International Immunopharmacology 3 7 (2003) 945-955